作者:Thomas J. Woltering、Wolfgang Wostl、Hans Hilpert、Mark Rogers-Evans、Emmanuel Pinard、Alexander Mayweg、Martin Göbel、David W. Banner、Jörg Benz、Massimiliano Travagli、Martina Pollastrini、Guido Marconi、Emanuele Gabellieri、Wolfgang Guba、Harald Mauser、Matteo Andreini、Helmut Jacobsen、Eoin Power、Robert Narquizian
DOI:10.1016/j.bmcl.2013.05.003
日期:2013.7
A series of amides bearing a variety of amidine head groups was investigated as BACE1 inhibitors with respect to inhibitory activity in a BACE1 enzyme as well as a cell-based assay. Determination of their basicity as well as their properties as substrates of P-glycoprotein revealed that a 2-amino-1,3-oxazine head group would be a suitable starting point for further development of brain penetrating compounds for potential Alzheimer's disease treatment. (C) 2013 Elsevier Ltd. All rights reserved.